Source: Journal of Molecular Liquids. Unidade: FCF
Assunto: QUIMIOTERÁPICOS
ABNT
D'ANGELO, Natália A et al. Development of PEG-PCL-based polymersomes through design of experiments for co-encapsulation of vemurafenib and doxorubicin as chemotherapeutic drugs. Journal of Molecular Liquids, v. 349, p. 1-14, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.molliq.2021.118166. Acesso em: 15 nov. 2024.APA
D'Angelo, N. A., Câmara, M. C. C., Noronha, M. A., Grotto, D., Chorilli, M., Lourenço, F. R., et al. (2022). Development of PEG-PCL-based polymersomes through design of experiments for co-encapsulation of vemurafenib and doxorubicin as chemotherapeutic drugs. Journal of Molecular Liquids, 349, 1-14. doi:10.1016/j.molliq.2021.118166NLM
D'Angelo NA, Câmara MCC, Noronha MA, Grotto D, Chorilli M, Lourenço FR, Rangel-Yagui C de O, Lopes AM. Development of PEG-PCL-based polymersomes through design of experiments for co-encapsulation of vemurafenib and doxorubicin as chemotherapeutic drugs [Internet]. Journal of Molecular Liquids. 2022 ; 349 1-14.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.molliq.2021.118166Vancouver
D'Angelo NA, Câmara MCC, Noronha MA, Grotto D, Chorilli M, Lourenço FR, Rangel-Yagui C de O, Lopes AM. Development of PEG-PCL-based polymersomes through design of experiments for co-encapsulation of vemurafenib and doxorubicin as chemotherapeutic drugs [Internet]. Journal of Molecular Liquids. 2022 ; 349 1-14.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.molliq.2021.118166